Publications by Dr Hilary Wynne - ePrints

Browsing publications by Dr Hilary Wynne.

Newcastle Authors	Title	Year
Dr Emma Kampouraki Dr Peter Avery Dr Tina Biss Dr Hilary Wynne Professor Farhad Kamali et al.	Assessment of exposure to direct oral anticoagulants in elderly hospitalised patients	2021
Dr Emma Kampouraki Dr Salah Abohelaika Dr Peter Avery Dr Tina Biss Dr Hilary Wynne et al.	Elderly people are inherently sensitive to the pharmacological activity of rivaroxaban: implications for DOAC prescribing	2021
Emma Kampouraki Dr Hilary Wynne Dr Peter Avery Professor Farhad Kamali	Validation of an algorithm to predict decline in INR following warfarin cessation in patients undergoing invasive procedures	2020
Dr Salah Abohelaika Dr Hilary Wynne Dr Peter Avery Dr Emma Kampouraki Professor Farhad Kamali et al.	Effect of genetic and patient factors on warfarin pharmacodynamics following warfarin withdrawal: Implications for patients undergoing surgery	2018
Dr Salah Abohelaika Dr Hilary Wynne Dr Peter Avery Dr Lisa Jones Professor Farhad Kamali et al.	Individual and monitoring centre influences upon anticoagulation control of AF patients on warfarin: a longitudinal multi-centre UK-based study	2018
Dr Emma Kampouraki Dr Peter Avery Dr Hilary Wynne Dr Tina Biss Dr John Hanley et al.	Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: A randomised clinical trial	2017
Salah Abohelaika Dr Hilary Wynne Dr Peter Avery Dr Patrick Kesteven Professor Farhad Kamali et al.	Impact of age on long-term anticoagulation and how gender and monitoring setting affect it: implications for decision making and patient management	2016
Salah Abohelaika Dr Hilary Wynne Dr Peter Avery Professor Farhad Kamali	Influence of CYP2C9 polymorphism on the fall in International Normalized Ratio in patients interrupting warfarin therapy before elective surgery	2015
Dr Salah Abohelaika Dr Hilary Wynne Professor Farhad Kamali	The effect of CYP2C9 polymorphism on inr decline in patients stopping warfarin before surgery	2015
Salah Abohelaika Dr Hilary Wynne Professor Farhad Kamali	The impact of genetics on the management of patients on warfarin awaiting surgery	2015
Salah Abohelaika Professor Farhad Kamali Dr Peter Avery Dr Patrick Kesteven Dr Hilary Wynne et al.	Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England	2014
Salah Abohelaika Dr Tina Biss Dr Hilary Wynne Professor Farhad Kamali	C0170: The Impact of Dietary Vitamin K on the Pharmacological Activity of FXa Inhibitor Rivaroxaban in Man	2014
Professor Farhad Kamali Dr Hilary Wynne Dr Patrick Kesteven Dr John Hanley Dr Jing Shen et al.	Improving the safety and efficacy of anticoagulation therapy for thromboembolic disease through Vitamin K	2013
Lilian Fairbairn Smith Dr Wei Cope Professor Farhad Kamali Dr Hilary Wynne	Effect of provision of the NHS NPSA oral anticoagulant therapy patient information pack upon patients' knowledge and anticoagulant control	2011
Professor Farhad Kamali Dr Hilary Wynne	Pharmacogenetics of warfarin	2010
Professor Farhad Kamali Dr Hilary Wynne	Pharmacogenetics and anticoagulation therapy	2009
Dr Ellen Hatch Dr Hilary Wynne Dr Peter Avery Professor Farhad Kamali	Application of a pharmacogenetic-based warfarin dosing algorithm derived from British patients to predict dose in Swedish patients	2008
Elizabeth Sconce Dr Hilary Wynne Professor Farhad Kamali	Factors Affecting Anticoagulation Response to Warfarin	2008
Elizabeth Sconce Dr Peter Avery Dr Hilary Wynne Professor Farhad Kamali	Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism influences the anticoagulation response subsequent to vitamin K intake: A pilot study	2008
Dr Ellen Hatch Elizabeth Sconce Dr Barry King Dr Hilary Wynne Professor Ann Daly et al.	Polymorphisms in genes associated with the vitamin K epoxide reductase complex do not affect warfarin dose requirement	2007
Elizabeth Sconce Dr Peter Avery Dr Hilary Wynne Professor Farhad Kamali	Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin	2007
Elizabeth Sconce Dr Hilary Wynne Professor Farhad Kamali	Vitamin K supplementation during oral anticoagulation: No real cause for concern [2]	2007
Elizabeth Sconce Professor Ann Daly Dr Tayyaba Khan Dr Hilary Wynne Professor Farhad Kamali et al.	APOE genotype makes a small contribution to warfarin dose requirements	2006
Elizabeth Sconce Dr Tayyaba Khan Professor Ann Daly Dr Hilary Wynne Professor Farhad Kamali et al.	Apolipoprotein E polymorphisms do not make a clinically significant contribution to warfarin dose requirements	2006
Dr Hilary Wynne Dr Tayyaba Khan Dr Peter Avery Peter Wood Professor Farhad Kamali et al.	Dietary related plasma vitamin C concentration has no effect on anticoagulation response to warfarin	2006
Elizabeth Sconce Dr Tayyaba Khan Professor Ann Daly Dr Hilary Wynne Professor Farhad Kamali et al.	Simvastatin results in a lower warfarin dose requirement due to a reduced clearance of warfarin	2006
Elizabeth Sconce Dr Tayyaba Khan Professor Ann Daly Dr Hilary Wynne Professor Farhad Kamali et al.	The impact of simvastatin on warfarin disposition and dose requirements	2006
Elizabeth Sconce Dr Tayyaba Khan Dr Hilary Wynne Dr Patrick Kesteven Dr Peter Avery et al.	[abstract] Pfizer poster communication prize - The influence of patient age, CYP2C9 genotype and height on warfarin dose requirements	2005
Elizabeth Sconce Dr Tayyaba Khan Dr Hilary Wynne Professor Farhad Kamali	Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation	2005
Elizabeth Sconce Dr Tayyaba Khan Dr Hilary Wynne Professor Farhad Kamali	Patients with unstable control have a poorer dietary intake of vitamin K compared with patients with stable control of anticoagulation	2005
Elizabeth Sconce Dr Tayyaba Khan Dr Hilary Wynne Dr Peter Avery Dr Barry King et al.	The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: Proposal for a new dosing regimen	2005
Professor Farhad Kamali Dr Tayyaba Khan Dr Barry King Dr Patrick Kesteven Peter Wood et al.	Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin	2004
Dr Tayyaba Khan Dr Hilary Wynne Dr Peter Avery Dr Patrick Kesteven Professor Farhad Kamali et al.	Dietary vitamin K influences intra-individual variability in anticoagulant response to warfarin	2004
Professor Farhad Kamali Dr Tayyaba Khan Dr Barry King Professor Ann Daly Dr Hilary Wynne et al.	The impact of patient age and genetic polymorphism of CYP2C9 on warfarin dose requirements	2004
Dr Tayyaba Khan Professor Farhad Kamali Dr Patrick Kesteven Dr Peter Avery Dr Hilary Wynne et al.	The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation	2004
Dr Hilary Wynne	Attitudes to monitoring of anticoagulation are influenced by age	2003
Dr Heather Lambert Dr Hilary Wynne	Patients' understanding of anticoagulant therapy	2003
Dr Hilary Wynne	Sensible prescribing for older people	2003
Helen Hickmott Dr Hilary Wynne Professor Farhad Kamali	The effect of simvastatin co-medication on warfarin anticoagulation response and dose requirements	2003
Professor Farhad Kamali Dr Hilary Wynne	The effect of stability of oral anticoagulant therapy upon patient-perceived health status and quality of life [4]	2003
Dr Hilary Wynne Dr Patrick Kesteven Professor Farhad Kamali	The impact of stability of oral anticoagulant therapy upon patient perceived health status and quality of life	2003
Professor Farhad Kamali Professor Ann Daly Dr Hilary Wynne	Warfarin sensitivity: Be aware of genetic influence	2003
Dr Hilary Wynne	Older people's views on the treatment and prevention of influenza in older people	2002
Professor Farhad Kamali Dr Hilary Wynne	The impact of stability of oral anticoagulant therapy upon patient perceived health status and quality of life	2002
Dr David Coady Dr Hilary Wynne	Are continuing care beds in private nursing homes the answer to providing care for the longer-term dying?	2001
Professor Farhad Kamali Dr Hilary Wynne Dr Patrick Kesteven	Temporal variations in plasma vitamin K and lipid concentrations and clotting factor activity in humans	2001
Karen Morgan Dr Hilary Wynne	Anticoagulation of older patients: a need to modify current practice	2000
Professor Farhad Kamali Dr Tim Butler Dr Hilary Wynne	The influence of (R)- and (S)-Warfarin, vitamin K and vitamin K epoxide upon warfarin anticoagulation	2000
Dr Hilary Wynne Professor Alan Boddy	The Association of Age and Frailty with the Pharmacokinetics and Pharmacodynamics of Metoclopramide	1993